MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state

Genes and Development

Volumn 23, Issue 6, 2009, Pages 694-707

  Yang, Zhihong ^a   MacQuarrie, Kyle L ^a,b   Analau, Erwin ^a   Tyler, Ashlee E ^a   Dilworth, F Jeffery ^c   Cao, Yi ^a   Diede, Scott J ^a   Tapseott, Stephen J ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

E2A; Musculiri; MyoD; Myogenesis; Rhabdomyosarcoma

Indexed keywords

HETERODIMER; MYOD PROTEIN; TRANSCRIPTION FACTOR E2A;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; MUSCLE DEVELOPMENT; MYF5 GENE; MYOBLAST; MYOD GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; STRUCTURAL GENE; UNINDEXED SEQUENCE;

AMINO ACID SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; HUMANS; MOLECULAR SEQUENCE DATA; MYOBLASTS; MYOD PROTEIN; PROTEIN MULTIMERIZATION; PROTEIN SPLICING; RHABDOMYOSARCOMA;

EID: 63049120997     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1765109     Document Type: Article

References (59)

1. Azmi, S., Ozog, A., and Taneja, R. 2004. Sharp-1/DEC2 inhibits skeletal muscle differentiation through repression of myogenic transcription factors. J. Biol. Chem. 279: 52643-52652.
2. Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L., and Weintraub, H. 1990. The protein Id: A negative regulator of helix-loop-helix DNA-binding protein. Cell 61: 49-59.
3. Bergstrom, D.A., Penn, B.H., Strand, A., Perry, R.L.S., Rudnicki, M.A., and Tapscott, S.J. 2002. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9: 587-600.
4. Berkes, C.A. and Tapscott, S.J. 2005. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 16: 585-595.
5. Berkes, C.A., Bergstrom, D.A., Penn, B.H., Seaver, K.J., Knoep-fler, P.S., and Tapscott, S.J. 2004. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol. Cell 14: 465-477.
6. Bhalla, S., Spaulding, C., Brumbaugh, R.L., Zagort, D.E., Massari, M.E., Murre, C., and Kee, B.L. 2008. Differential roles for the E2A activation domains in B lymphocytes and microphages. J. Immunol 180: 1694-1703.
7. Buas, M.F., Kabak, S., and Kadesch, T. 2009. Inhibition of myogenesis by Notch: Evidence for multiple pathways. J. Cell. Physiol. 218: 84-93.
8. Chen, A.C., Kraut, N., Groudine, M., and Weintraub, H. 1996. I-mf, a novel myogenic repressor, interacts with members of the MyoD family. Cell 86: 731-741.
9. Cobb, L.J., Salih, D.A., Gonzalez, I., Tripathi, G., Carter, E.J., Lovett, E, Holding, C., and Pell, J.M. 2004. Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti- apoptotic function. J. Cell Sci. 117: 1737-1746.
10. Conway, K., Pin, C., Kiernan, J.A., and Merrifield, P. 2004. The E protein HEB is preferentially expressed in developing muscle. Differentiation 72: 327-340.
11. Dilworth, F.J., Seaver, K.J., Fishburn, A.L., Htet, S.L., and Tapscott, S.J. 2004. In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation. Proc. Natl. Acad. Sci. 101:11593-11598.
12. Fiddler, T.A., Smith, L., Tapscott, S.J., and Thayer, M.J. 1996. Amplification of MDM2 inhibits MyoD-mediated myogenesis. Mol. Cell. Biol. 16: 5048-5057.
13. Flora, A., Garcia, J.J., Thaller, C., and Zoghbi, H.Y. 2007. The E- protein Tcf4 interacts with Mathl to regulate differentiation of a specific subset of neuronal progenitors. Proc. Natl. Acad. Sci. 104: 15382-15387.
14. Fujimoto, K., Hamaguchi, H., Hashiba, T., Nakamura, T., Kawamoto, T., Sato, F., Noshiro, M., Bhawal, U.K., Suardita, K., and Kato, Y. 2007. Transcriptional repression by the basic helix-loop-helix protein Dec2: Multiple mechanisms through E-box elements. Int. J. Mol. Med. 19: 925-932.
15. Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. 2004. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 5: R80. doi: 10.1186/gb-2004-5-10- r80.
16. Gingras, A.-C., Aebersold, R., and Raught, B. 2005, Advances in protein complex analysis using mass spectrometry. J. Physiol. 563: 11-21.
17. Graf Finckenstein, F., Shahbazian, V., Davicioni, E., Ren, Y.-X., and Anderson, M.J. 2008. PAX-FKHR functions as pangene by simultaneously inducing and inhibiting myogenesis, Oncogene 27: 2004-2014.
18. Hahn, H., Wojnowski, L., Specht, K., Kappler, R., Calzada-Wack, J., Potter, D., Zimmer, A., Muller, U., Samson, E., Quintanilla- Martinez, L., et al. 2000. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J. Biochem. 27: 28341-28344.
19. Inaba, T., Roberts, W.M., Shapiro, L.H., Jolly, K.W., Raimondi, S.C, Smith, S.D., and Look, A.T. 1992. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257: 531-534.
20. King, A.M., Van der Put, E., Blomberg, B.B., and Riley, R,L. 2007. Accelerated Notch-dependent degradation of E47 proteins in aged B cell precursors is associated with increased ERK MAPK activation. J. Immunol. 178: 3521-3529.
21. Kophengnavong, T., Michnowicz, J.E., and Blackwell, T.K. 2000. Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations. Mol. Cell. Biol. 20: 261-272.
22. Ruroda, K., Tani, S., Tamura, R., Minoguchi, S., Kurooka, H., and Honjo, T. 1999. Delta-induced Notch signaling mediated by RBP-f inhibits MyoD expression and myogenesis. J. Biol. Chem. 274: 7238-7244.
23. Langenau, D.M., Keefe, M.D., Storer, N.Y., Guyon, J.R., Kutok, J.L., I.e. X., Goessling, W., Neuberg, D.S., Kunkel, L.M., and Zon, L.I. 2007. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes & Dev. 21: 1382-1395.
24. Lu, Q., Wright, D.D., and Kamps, M.P. 1994. Fusion with E2A converts the Pbxl homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(l;19) translocation. Mol. Cell. Biol. 14: 3938-3948.
25. Lu, J.-R., Webb, R., Richardson, J.A., and Olson, E.N. 1999. MyoR: A muscle-restricted basic helix-loop-helix transcriptional factor that antagonizes the actions of MyoD. Proc. Natl. Acad. Sci. 96: 552-557.
26. Lu, J.-R., Bassel-Duby, R., Hawkins, A., Chang, P., Valdez, R., Wu, H., Gan, L., Shelton, J.M., Richardson, J.A., and Olson, E.N. 2002. Control of facial muscle development by MyoR and capsulin. Science 298: 2378-2381.
27. Marampon, F., Ciccarelli, C., and Zani, B.M. 2006. Down- regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Mol. Cancer 5: 31. doi: 10.1186/1476-4598-5-31.
28. Markus, M., Du, Z.-M., and Benezra, R. 2002. Enhancer-specific modulation of E protein activity. J. Biol Chem. 277: 6469- 6477.
29. Martindill, D.M., Risebro, C.A., Smart, N., Franco-Viseras Mdel, M., Rosario, CO., Swallow, C.J., Dennis, J.W., and Riley, P.R. 2007. Nucleolar release of Handl acts as a molecular switch to determine cell fate. Nat. Cell Biol. 9: 131-141.
30. Massari, M.E. and Murre, C. 2000. Helix-loop-helix proteins: Regulation of transcription in eukaryotic organisms. Mol. Cell. Biol. 20: 429-440.
31. Massari, M.E., Grant, P.A., Pray-Grant, M.G., Berger, S.L., Workman, J.L., and Murre, C. 1999. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell 4: 63-73.
32. Mathas, S., Janz, M., Hummel, F, Hummel, M., Wollert-Wulf, B., Lusatis, S., Anagnostopoulos, I., Lietz, A., Sigvardsson, M., Jundt, F., et al. 2006. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprog- ramming of neoplastic B cells in Hodgkin lymphoma. Nat. Immunol. 7: 207-215.
33. McAllister, R.M., Melnyk, J., Finkelstein, J.Z., Adams, Jr., E.C., and Gardner, M.B. 1969. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 24: 520-526.
34. Merlino, G. and Helman, L.J. 1999. Rhabdomyosarcoma-Working out the pathways. Oncogene 18: 5340-5348.
35. Mizrak, D., Brittan, M., and Alison, M.R. 2008. CD133: Molecule of the moment. J. Pathol. 214: 3-9.
36. Neuhold, L.A. and Wold, B. 1993. HLH forced dimers: Tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id. Cell 74:1033-1042.
37. Nofziger, D., Miyamoto, A., Lyons, K.M., and Weinmaster, G. 1999. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 12: 1689- 1702.
38. Nutt, S.L. and Kee, B.L. 2007. The transcriptional regulation of B cell lineage commitment. Immunity 26: 715-725.
39. Otten, A.D., Firpo, E.J., Gerber, A.N., Brody, L.L., Roberts, J.M., and Tapscott, S.J. 1997. Inactivation of MyoD-mediated expression of p21 in tumor cell lines, Cell Growth Differ. 8: 1151-1160.
40. Peinado, H., Olmeda, D., and Cano, A. 2007. Sanil, ZEB and bHLH factors in tumor progression: An alliance against the epithelial phenotype? Nat. Rev. Cancer 7: 415-428.
41. Puri, P.L., Wu, Z., Zhang, P., Wood, L.D., Bhakta, K.S., Han, J., Feramisco, J.R., Karin, M., and Wang, J.Y. 2000. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes & Dev. 14: 574-584.
42. Rigaut, G., Sehevehenko, A., Rutz, B., Wilm, M., Mann, M., and Seraphin, B. 1999. A generic protein purification method for protin complex characterization and proteome exploration. Nat. Biotechnol. 17: 1030-1032.
43. kip2 to regulate cell cycle in neural cells. Mol. Cell. Biol. 26: 4351-4361.
44. Salih, DA., Tripathi, G., Holding, C., Szestak, T.A., Gonzalez, M.I., Carter, E.J., Cobb, L.J., Eiseman, J.E., and Pell, J.M. 2004. Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl. Acad. Sci. 101: 4314-4319.
45. Sawado, T., Igarashi, K., and Groudine, M. 2001. Activation of β- major globin gene transcription is associated with recruitment of NF-E2 to the β-globin LCR and gene promoter. Proc. Natl. Acad. Sci. 98: 10226-10231.
46. Schwartz, R., Engel, I., Fallahi-Sichani, M., Petrie, H.T., and Murre, C. 2006. Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development. Proc. Natl. Acad. Sci. 103: 9976-9981.
47. Sharp, R., Recio, J.A., Jhappan, C., Otsuka, T., Liu, S., Yu, Y., Liu, W., Anver, M., Navid, F., Helman, L.J., et al. 2002. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomgenesis. Nat. Med. 8: 1276-1280.
48. Snider, L., Thirlwell, H., Miller, J.R., Moon, R.T., Groudine, M., and Tapscott, S.J. 2001. Inhibition of Tcf3 binding by I-mfa domain proteins. Mol. Cell. Biol. 21: 1866-1873.
49. St-Pierre, B., Flock, G., Zacksenhaus, E., and Egan, S.E. 2002. Stral3 homodimers repress transcription through class B E- box elements. J. Biol. Chem. 277: 46544-46551.
50. Strausberg, R.L., Feingold, E.A., Grouse, L.H., Derge, J.G., Klausner, R.D., Collins, F.S., Wagner, L., Shenmen, C.M., Schuler, G.D., Altschul, S.F., et al. 2002. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequence. Proc. Natl. Acad. Sci. 99: 16899- 16903.
51. Sun, J., Kamei, C.N., Layne, M.D., Jain, M.K., Liao, J.K., Lee, M.E., and Chin, M.T. 2001. Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. J. Biol. Chem. 276: 18591-18596.
52. Tapscott, S.J., Davis, R.L., Thayer, M.J., Cheng, P.F., Weintraub, H, and Lassar, A.B. 1988. MyoDl: A nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242: 405-411.
53. Tapscott, S.J., Thayer, M.J., and Weintraub, H. 1993. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259: 1450-1453.
54. von Scheven, G., Bothe, I., Ahmed, M.U., Alvares, L.E., and Dietrich, S. 2006. Protein and genomic organization of vertebrate MyoR and Capsulin and their expression during avian development. Gene Expr. Patterns 6: 383-393.
55. Wang, H., Garzon, R., Sun, H., Ladner, K.J., Singh, R., Dahlman, J., Cheng, A., Hall, B.M., Qualman, S.J., Chandler, D.S., et al. 2008. NF-κB-YYl-MiR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14: 369- 381.
56. Weintraub, H., Davis, R., Tapscott, S.J., Thayer, M., Krause, M., Benezra, R., Blackwell, T.K., Turner, D., Rupp, R., Hollen- berg, S., et al. 1991. The myoD gene family: Nodal point during specification of the muscle cell lineage. Science 251: 761-766.
57. Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T., and Roeder, R.G. 2004, E protein silencing by the leukemogenic AML1- ETO fusion protein. Science 305: 1286-1289.
58. Zhao, R and Hoffman, E.P. 2006. Musculin isoforms and repression of MyoD in muscle regeneration. Biochem. Biophys. Res. Commun. 342: 835-842.
59. Zhuang, Y., Cheng, P., and Weintraub, H. 1996. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell. Biol. 16: 2898-2905.